Visualizing changes in electron distribution in coupled chains of cytochrome bc_{1} by modifying barrier for electron transfer between the FeS cluster and heme c_{1} by Cieluch, Ewelina et al.
Biochimica et Biophysica Acta 1797 (2010) 296–303
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbab ioVisualizing changes in electron distribution in coupled chains of cytochrome bc1 by
modifying barrier for electron transfer between the FeS cluster and heme c1
Ewelina Cieluch, Krzysztof Pietryga, Marcin Sarewicz, Artur Osyczka ⁎
Department of Biophysics, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, ul. Gronostajowa 7, 30-307 Kraków, PolandAbbreviations: Eh, ambient redox potential; Em, re
redox midpoint potential at pH 7; Em9, redox midpoint p
sulfur cluster; Q, ubiquinone; QH2, ubihydroquinone; Rb
⁎ Corresponding author. Tel.: +48 12 664 6348; fax:
E-mail address: artur.osyczka@uj.edu.pl (A. Osyczka
0005-2728 © 2009 Elsevier B.V.
doi:10.1016/j.bbabio.2009.11.003
Open access under CC BYa b s t r a c ta r t i c l e i n f oArticle history:
Received 22 September 2009
Received in revised form 9 November 2009
Accepted 10 November 2009
Available online 14 November 2009
Keywords:
Electron transfer
Cytochrome bc1
Complex III
Q cycle
Redox midpoint potential
Kinetic modelCytochrome c1 of Rhodobacter (Rba.) species provides a series of mutants which change barriers for electron
transfer through the cofactor chains of cytochrome bc1 by modifying heme c1 redox midpoint potential.
Analysis of post-flash electron distribution in such systems can provide useful information about the
contribution of individual reactions to the overall electron flow. In Rba. capsulatus, the non-functional low-
potential forms of cytochrome c1 which are devoid of the disulfide bond naturally present in this protein
revert spontaneously by introducing a second-site suppression (mutation A181T) that brings the potential of
heme c1 back to the functionally high levels, yet maintains it some 100 mV lower from the native value. Here
we report that the disulfide and the mutation A181T can coexist in one protein but the mutation exerts a
dominant effect on the redox properties of heme c1 and the potential remains at the same lower value as in
the disulfide-free form. This establishes effective means to modify a barrier for electron transfer between the
FeS cluster and heme c1 without breaking disulfide. A comparison of the flash-induced electron transfers in
native and mutated cytochrome bc1 revealed significant differences in the post-flash equilibrium distribution
of electrons only when the connection of the chains with the quinone pool was interrupted at the level of
either of the catalytic sites by the use of specific inhibitors, antimycin or myxothiazol. In the non-inhibited
system no such differences were observed. We explain the results using a kinetic model in which a shift in
the equilibrium of one reaction influences the equilibrium of all remaining reactions in the cofactor chains. It
follows a rather simple description in which the direction of electron flow through the coupled chains of
cytochrome bc1 exclusively depends on the rates of all reversible partial reactions, including the Q/QH2
exchange rate to/from the catalytic sites.
© 2009 Elsevier B.V. Open access under CC BY license.1. Introduction
Bioenergetic enzymes use chains of cofactors to transfer electrons
over long distances and connect catalytic sites with substrate redox
pools. In such systems, the overall direction of electron flow is a
resultant of reversible partial reactions. When one, linearly organized
chain is involved and the system behaves in purely electrochemical
manner without any gating, the distribution of electrons among
cofactors is relatively simple to predict based on equilibrium thermo-
dynamic calculations. However complications arise when more than
one chain is involved and the electron flow in one chain is somehow
linked with the electron flow in the other chain or the group of chains.
One of the prominent examples of this sort of arrangement is a two-
chain assembly in cytochrome bc1 (complex III), a common component
of respiratory and photosynthetic electron transfer systems.dox midpoint potential; Em7,
otential at pH 9; FeS, 2 iron–2
a., Rhodobacter; WT, wild type
+48 12 664 69 02.
).
 license.In this enzyme a c-chain comprising high-potential cytochromes
c1 and c and the 2 iron–2 sulfur cluster (FeS) and the b-chain
comprising two low-potential hemes b (bL and bH) and quinone of the
Qi site are linked together by the action of the centrally located
quinone binding Qo site. This site catalyzes a reversible two-electron
oxidation of hydroquinone with one electron delivered into the c-
chain and the other electron delivered into the b-chain. This is an
integral part of the Q cycle used by the enzyme to catalyze electron
transfer between quinone and cytochrome c [1–3].
Despite intense studies, our knowledge about the mechanism of
the Qo site catalysis and the way the two chains are connected is still
not complete and thus remains a subject of intense debate. For the Qo
site reaction, several variations of either sequential or concerted
mechanisms are considered [4–9]. For the chain connection, a
thermodynamic coupling without any gating, or a coupling with
various combinations of long-range allosteric interactions between
the chains are considered [4–8,10–15]. The latter ones often assume
some level of control over the large-scale motion of the FeS head
domain, which during the catalytic cycle moves between the states
where the FeS cluster approaches the Qo site and the states where it
approaches heme c1 [16]. Additional complications come from the
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of intra-dimer interactions are also included in many of the proposed
mechanisms [10,11,13,17,18]. The whole debate is intensified by the
observation that under certain conditions cytochrome bc1 becomes
vulnerable to superoxide production. This is considered to be a side
reaction of the Q cycle with the most commonly accepted view that
electrons leak on oxygen from a semiquinone formed in the Qo site
[4,19–22]. How this occurs is not known, but highly desired to be
known as it is expected to improve our knowledge about the
mechanism of the Qo site action and to clarify some of the
medically-related issues of radical production in living cells.
A convenient way to access experimentally certain electron
transfer reactions of cytochrome bc1 is provided by membranes of
purple photosynthetic bacteria where cytochrome bc1 can be light-
activated through the allied photosynthetic reaction center. The
electron flow through the two chains of cytochrome bc1 can be
specifically manipulated by the use of inhibitors of catalytic Qo or Qi
sites in combination with various site-directed mutations that
purposely change some of the properties of cofactors [23]. Of those,
mutations that target cytochrome c1 of Rhodobacter species turned
out to be particularly useful, as they provided a whole series of
variants which suitably alter electron transfer by modifying values of
heme c1 midpoint potential [24–27].
One group of mutants includes the forms withmutations changing
the sixth axial ligand to heme iron. In this case, an unusual tolerance of
cytochrome c1 of Rba. sphaeroides to the alternations in the heme
ligation pattern made it possible to obtain a whole range of mutants
with modified potential of heme c1 which exposed the ultimate
thermodynamic limits of operation of the cofactor chains in
cytochrome bc1 [27]. The other group of mutants includes the low-
potential forms of closely related Rba. capsulatus cytochrome c1
which are devoid of the disulfide bond naturally present in this
species [26,28] (see Fig. 1) and in Rba. sphaeroides [29]. These non-
functional forms revert spontaneously by introducing a second-site
suppression (mutation A181T) that brings the potential of heme c1
back to the functionally high level yetmaintains it some 100mV lower
from the native value. The revertants leave the disulfide bridge
unrepaired [26].
In this work we report on some of the structural and redox
properties of the mutant of cytochrome c1 of Rba. capsulatus in which
the mutation A181T was introduced to the native protein containing
all cysteine residues. We observe that the disulfide and A181T can
coexist, but the mutation exerts a dominant effect on the redox
properties of heme c1 and the potential remains at the same lowerFig. 1. Ribbon model of the crystal structure of the heme domain of cytochrome c1
subunit of Rba. capsulatus cytochrome bc1 [28]. Heme c1 (red sticks) is axially ligated by
histidine and methionine (greens sticks). Position A181 (magenta spheres) is located
within the sixth axial ligand domain. Position Y152 (orange line) is located between the
two cysteine residues that form disulfide bond (yellow sticks).value as in the disulfide-free form. This established effective means to
modify a barrier for electron transfer between the FeS cluster and
heme c1 without breaking disulfide or changing the ligand to heme
iron. We compared the flash-induced electron transfer in native and
mutated cytochrome bc1 and found significant differences in the post-
flash equilibrium distribution of electrons in the c-chain only when
the connection of the chains with the quinone pool was interrupted at
the level of either the Qo or the Qi site. To explain the results we
developed a kinetic model which in our view improves the general
understanding of electron flow through the coupled chains of
cytochrome bc1.
2. Materials and methods
2.1. Bacterial strains, plasmids, and general molecular genetic techniques
Rba. capsulatus strains and E. coli (HB101) were grown in MPYE
(mineral-peptone-yeast-extract) and LB media, respectively, supple-
mented with appropriate antibiotics as needed [30]. Photosynthetic
growth of Rba. capsulatus strains was tested on MPYE plates using
anaerobic jars (GasPak System, BBL) at 30 °C under continuous light.
Rba. capsulatus strains with mutated cytochrome bc1 were generated
as described previously [31], using the genetic system which was a
generous gift of Prof. F. Daldal (University of Pennsylvania, Philadel-
phia, USA). Themutations A181T and A181T/Y152Rwere constructed
by site directed mutagenesis. A 0.51 kb SphI/SfuI fragment of petC
gene was amplified by PCR with the set of two primers ASUII-F: 5′-
CTTCAGCTTCGAAGGGATCTTCG (SfuI site is shown in italic) and A181T-
R: 5′-GGGCATGCGCGTCCAGCTGC (point mutation is shown in bold,
SphI site is in italic). The template DNA for PCR was either pPET1
[31] or pPET1-cY152R [26], a derivative of pBR322 containing either a
wild-type copy of petABC or a copy of petABC with a single mutation
Y152R in petC, respectively. The resulting 0.51 kb PCR products
containing either A181T or A181T/Y152R in petCwere first exchanged
with their wild-type counterparts in pPET1 using the restriction
enzymes SphI/SfuI and then inserted into pMTS1 (the expression
vector containing a copy of petABC) using the restriction enzymes
SfuI/HindIII. The entire petC gene was sequenced to ensure that the
constructs contained the desired mutation and no other mutations.
The mutated variants of pMTS1 were introduced into MT-RBC1 strain
(petABC-operon deletion background) via triparental crosses as
described in ref. [31]. In each case, the presence of engineered
mutations was confirmed by sequencing the plasmid DNA isolated
from the mutated Rba. capsulatus strains.
2.2. Isolation of cytochrome bc1 and electrophoresis
The chromatophore membranes were prepared from semiaerobi-
cally grown cultures of Rba. capsulatus as described previously
[31,32]. Membranes were solubilized with dodecyl maltoside and
the purification of cytochrome bc1 by the ion-exchange chromatog-
raphy was performed as described in ref. [32]. Sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) was performed as
described in ref. [26]. Samples of protein were incubated under
reducing conditions at 60 °C for 5min prior to the loading on gels (15%
linear separating gel was used) and the gels were stained with
Coomassie blue. The presence of disulfide bridge in cytochrome c1
containing A181T was verified using the factor Xa cleavage assay as
descried in detail in ref. [26] on the form that contained the cleavage
site introduced by mutation Y152R.
2.3. Optical spectroscopy and redox potentiometry
Optical spectra for b- and c-type cytochromes were recorded using
Shimadzu UV-2450 spectrophotometer. The difference spectra were
obtained with samples that were first oxidized by an addition of a
Table 1
Effect of A181T mutation on redox properties of cytochrome c1 with and without the
presence of the disulfide bridge.
PSa Em7 isolatedb Em membranesc Disulfide
bridge
WT + 335 328(pH7) +
A181T + 235 229(pH7); 223(pH9) +d
A181T/C144A/C167A + 228 ND -
a Photosynthetic phenotype; + indicates photosynthetic growth ability.
b Potential of heme c1 in isolated complexes.
c Potential of heme c1 in membranes where titrations show an additional component
of + 377 mV (cytochromes c2 and cy); (pH7) and (pH9) indicate pH for which a value of
Em is given.
d Based on the results of the factor Xa cleavage assay performed with a form
containing the factor Xa cleavage site (A181T/Y152R).
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reduced by using either sodium ascorbate (added to a final
concentration of 2 mM) or a minimal amount of solid sodium
dithionite. Chemical oxidation–reduction midpoint potentials titra-
tions of hemes c in membranes or purified complexes were performed
as described in ref. [33]. The titrations were performed in 50 mM
MOPS (for pH 7), 50 mM Tris (for pH 9) containing 100 mM KCl, and
redox mediators: tetrachlorohydroquinone, 2,3,5,6-tetramethyl phe-
nylenediamine, 1,2-naphthoquinone-4-sulfonate, 1,2-naphthoqui-
none, phenazine methosulfate, phenazine ethosulfate, and
duroquinone at concentration of 5–15 μM. The optical changes that
accompanied redox potential change were recorded in the α-region
(500–600 nm) and the redox midpoint potentials (Em) of hemes c
were determined by fitting the 552–542 nm difference to an n=1
Nernst equation with one or two components, for the measurements
with isolated complexes or membranes, respectively.
2.4. Flash-induced electron transfer measurements
Flash-activated turnover kinetics of cytochrome bc1 were per-
formed essentially as described in refs. [34–36], on a home-built
double wavelength time-resolved spectrophotometer. The spectro-
photometer consisted of a SP-20 Flash Lamp System (Rapp OptoElec-
tronic, GmbH) and an optical assembly equipped with two H-20Vis
monochromators (JY Horiba) (a generous gift of Prof. P. Leslie Dutton,
University of Pennsylvania, Philadelphia, USA) and the two 9828SB07
photomultipliers in QL30 housing (Electron Tubes). An activation of
the sample and an acquisition of the data were controlled by a locally
written program using the NI PXI-1042Q interface (National Instru-
ments). The electronic assembly was designed by T. Oleś and J. Kozioł
(Jagiellonian University). For the measurements, chromatophore
membranes were suspended in appropriate buffer: 50 mM MES (for
pH 6), 50 mM MOPS (for pH 7), or 50 mM Tris (for pH 9) containing
100 mM KCl, 3.5 μM valinomycin, and redox mediators: 7 μM 2,3,5,6-
tetramethyl-1,4-phenylenediamine, 1 μM phenazine methosulfate,
1 μM phenazine ethosulfate, 5.5 μM 1,2-naphthoquinone, 5.5 μM 2-
hydroxy-1,4-naphthoquinone. The sample was poised at an ambient
potential of 150 mV, 100 mV, or -20 mV for pH 6, 7, or 9, respectively.
Transient cytochrome c and b reduction kinetics initiated by a short
saturating flash (10 μs) from a xenon lamp were followed at 550–
540 nm and 560–570 nm, respectively. Inhibitors antimycin A,
myxothiazol, and stigmatellin were used at final concentrations of 7,
7 and 1.5 μM, respectively.
2.5. Kinetic model of flash-activated electron transfer
Simulation of flash-activated curves were performed using
XPPAUT 5.85 [37] included in Ubuntu Linux 8.10. The model was
built from a set of 28 differential equations, from which 24 describe
the changes in the concentrations of particular states of cytochrome
bc1 monomer (i.e., redox states of cofactors, occupancy of Qo site,
position of the FeS head domain) and the remaining four equations
describe the changes in the concentrations of substrates (i.e., quinone
(Q), quinol (QH2) and cytochrome c). The equations were constructed
taking into account the following assumptions: (1) molar ratio of total
quinone to cytochrome bc1 monomer is 20:1, (2) single flash
generates two oxidized molecules of cytochrome c per cytochrome
bc1 monomer [38], (3) affinities of Q and QH2 to the Qo are equal, (4)
all steps are reversible, (5) all reactions within a monomer are
independent on each other and each monomer can work indepen-
dently, (6) reduction of Q and oxidation of QH2 at the Qo site are both
concerted. The individual reactions in the high-potential c-chain were
taken for detailed calculations. The b-chain, for simplicity, was
described by one equation, in which the presence or absence of
inhibitors was expressed by variations in the time constants
describing concerted electron transfer from QH2 to FeS and heme bLor from heme bL and FeS to Q at the Qo site. At the beginning of the
simulations the concentrations of Q and QH2 were the same and all Qo
sites of the cytochrome bc1 were occupied. The effect of change in the
difference of potential between the FeS center and heme c1 was
included in the time constants for electron transfer rates between FeS
and heme c1 estimated using the equations of Moser and Dutton
[39,40]. In these calculations, the distance of 11.4 Å between cofactors
and reorganization energy of 0.7 eV were taken [41]. All remaining
rate constants were adjusted to correctly reproduce the experimental
curves. The simulated curves were obtained by numerical integration
of the differential equations with XPPAUT using Gear's algorithm and
the outputs were analyzed using home-written LabView program.
The XPPAUT script used for simulations is included in Supplementary
Material.3. Results and discussion
3.1. Structural and redox properties of the family of A181T
(βXM) mutants
Earlier work has established two independent structural motifs
that contribute to controlling the integrity of the heme binding pocket
to raise the redox potential in cytochrome c1 of Rba. capsulatus [26].
The native protein employs, an uncommon for cytochromes c,
disulfide anchoring of the extra loop (C144-C167) adjacent to the
domain of the sixth axial ligand of heme iron (M183) (Fig. 1). The
engineered disulfide-free protein (containing cysteine to alanine
mutations at positions 144 and 167) has a loosened structure with the
redox midpoint potential lowered to nonfunctional levels unless an
additional suppressor mutation is present in the form of a β-branched
amino acid two residues away from the heme-ligating methionine
(A181T) (Fig. 1). With this mutation (considered as a part of a so
called βXM motif, naturally present in many other cytochromes c)
cytochrome c1 reaches back a functional range of high redox potential
(Em7=227 mV). The value of the potential is, however, still lower by
100 mV from the value of native cytochrome c1 [26].
To test the effect of the presence of the βXM motif alone, we
introduced A181T to the protein in which the cysteines at positions
144 and 167 were not changed. With this mutation, cytochrome bc1 is
functional in vivo (PS+ phenotype) (Table 1) and the optical
difference spectra of purified complexes have the ascorbate-reducible
component at 552 nm reminiscent of the presence of high potential
cytochrome c (Fig. 2, dashed line). The shape of the spectra of
cytochrome bc1 fully reduced with dithionite (Fig. 2, solid line)
immediately suggests some similarities between A181T and A181T/
disulfide-free cytochrome c1: in both spectra the 552 nm component
of cytochrome c1 is less separated, in comparison to the wild type,
from the component at 560 nm corresponding to cytochromes b. Even
more significantly, the redoxmidpoint potential of A181T cytochrome
c1 has a very close value to that of A181T/disulfide-free cytochrome c1
Fig. 2. Optical redox difference spectra of cytochrome bc1 isolated fromwild type (A), A181T mutant (B) and A181T/C144A/C167A mutant (C). Solid and dashed lines correspond to
dithionite minus ferricyanide and ascorbate minus ferricyanide spectra, respectively.
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wild-type (Table 1, Fig. 3).
This apparently dominant effect of mutation A181T on the redox
properties of cytochrome c1 raises an interesting structural question
as to howmuch the specific orientation of the loop regions reinforced
by a reduced conformational flexibility of T181 [26] differs from the
native structure. The most severe case would feature A181T not
allowing the disulfide to form even with C144 and C167 present. To
test this, we used a factor Xa cleavage assay (described in detail in ref.
[26]) on a variant of A181T which contained a factor Xa cleavage site
in the region between C144 and C167 (i.e., had additional mutation
Y152R, see Fig. 1). The results (Fig. S1 in Supplementary Material)
revealed that a disulfide bond does form in A181T/Y152R (and by
extrapolation in A181T) indicating that the A181T mutation and the
disulfide can coexist in one protein (Table 1). Thus, to explain the very
same drop in the redox potential of both of A181T mutants (i.e., in
disulfide-free and disulfide-containing form), one may speculate that
those mutants adopt similar overall conformation which somehow
differs from the native conformation, yet features the loop regions
oriented in such a manner that disulfide bond is formable provided
that C144 and C167 are present (i.e., the alanines at positions 144 and
167 in disulfide-free A181T mutant are in approximately the same
orientation as the cysteines 144 and 167 in disulfide-containing
A181T).
To what extent the A181T mutants differ structurally from the
native cytochrome c1 and how this relates to the observed change in
the redox potential requires further studies which are beyond the
scope of this work.We focused on using the redox properties of A181TFig. 3. Potentiometric dark equilibrium titration of heme c1 in isolated wild-type
cytochrome bc1 (closed black circles), A181T mutant (open grey squares) and A181T/
C144A/C167A triple mutant (open black triangles). The titrations were performed at
pH 7, and experimental data were fit to the Nernst equation for a one-electron couple.
The Em values obtained are shown in the figure and also listed in Table 1.mutants as the effective means to unravel some of the mechanistic
elements of electron transfer within the cofactor chains of cytochrome
bc1. For this purpose we chose A181T mutant containing disulfide
bond. Even though, as discussed earlier, all A181T mutants might
adopt similar overall conformation, the possibility that it more
resembles the native structure (i.e., structural “side effects” are
minimized) is always higher in the disulfide-containing rather than
disulfide-free form.3.2. Light-induced electron transfer in wild type and A181T
Fig. 4 compares kinetic transients of electron transfer in the c-
chain of wild type cytochrome bc1 with those of A181T mutant. The
characteristic and well-known traces recorded for the wild type at pH
7 and ambient potential of 100 mV (which maintains the Q pool half-
reduced) include: the trace for the non-inhibited system, where the
light-induced oxidation of cytochromes c is followed by a complete
re-reduction phase (Fig. 4A, black); the trace with the Qi inhibitor
antimycin present where cytochrome c re-reduction occurs but on the
millisecond timescale is not completed (Fig. 4A, red); and the traces
with two specific inhibitors of the Qo site, stigmatellin or myxothiazol
(Fig. 4A, green or blue, respectively). The trace with stigmatellin
reveals the full extent of flash-oxidized cytochrome c (in this case the
FeS cluster is locked at the Qo site due to interactions with inhibitor
and can not interact directly with cytochrome c1), while the trace
with myxothiazol reveals the amount of cytochrome c that remains
oxidized after initial reduction by the pre-reduced FeS cluster (in this
case the FeS cluster is not locked at the Qo site and can interact with
cytochrome c1); see description of myxothiazol and stigmatellin
traces in ref. [42]. The rate of reduction of cytochrome c by the pre-
reduced FeS cluster is faster than the time resolution of the method,
thus in the presence of myxothiazol we only register the final level of
oxidized cytochrome c which gives a smaller amplitude than the
amplitude of oxidized cytochrome c recorded in the presence of
stigmatellin. The corresponding traces of heme b oxidation/reduction
are not shown; only the rate of heme b reduction in the presence of
antimycin is reported in Table 2.
In the next parts, the difference in the level of the oxidized
cytochrome c recorded in the presence of stigmatellin and the level of
cytochrome c re-reduced in the presence of antimycin will be referred
as “antimycin phase,” and the difference between the level of oxidized
cytochrome c in the presence of stigmatellin and that recorded in the
presence of myxothiazol will be referred as “myxothiazol phase.”11 In flash experiments, traces recorded in the presence of stigmatellin often show
unspecific drift upwards (this drift becomes larger as pH increases), as most clearly
seen in Fig. 4A. For each trace, the beginning of the linear part of the curve was taken
to calculate the amplitude of antimycin and myxothiazol phase.
Fig. 4. Flash-activated cytochrome c oxidation and re-reduction in chromatophores containing wild-type cytochrome bc1 (A, C) and the A181T mutant (B, D). Kinetic transients at
550–540 nmwere recorded at pH 7 (A, B) or pH 6 (C, D) with the Q pool half-reduced, in the absence of inhibitors (black) and in the presence of antimycin (red), myxothiazol (blue)
or stigmatellin (green).
Table 3
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the A181T mutant.
In A181T under the same experimental conditions (pH 7, Eh
100 mV) the re-reduction of cytochrome c in the absence of any
inhibitors is slower but complete (Fig. 4B, black, see Table 2 for
corresponding rate of heme b reduction measured in the presence of
antimycin). Remarkably, the antimycin phase has significantly lower
amplitude than that of wild-type (less cytochrome c gets re-reduced
in the presence of antimycin) (Fig. 4B, Table 3). Also the myxothiazol
phase is smaller (in the mutant it is approximately one fourth of the
total amplitude of flash-oxidized cytochrome c seen in the presence of
stigmatellin, while in the wild-type it is approximately one third of
the total amplitude) (Fig. 4B, Table 3).
At acidic pH (pH 6, Eh 150 mV maintaining the Q pool half-
reduced), the antimycin phase in the wild type and the mutant (Fig.
4C, D; Table 3) is smaller comparing to the respective phases recorded
at pH 7. Themyxothiazol phase remains similar in thewild type, while
it slightly diminishes in the mutant (Fig. 4C, D; Table 3), when again
compared to the respective phases recorded at pH 7. At alkaline pH
(pH 9, Eh -20 mV) the antimycin phase much increases both in the
wild type and the mutant, approaching the level of fully re-reduced
cytochrome c in the absence of inhibitors (Table 3). The myxothiazol
phase in both cases also increases to reach about a half of the total
amplitude of flash-oxidized cytochrome c seen in the presence of
stigmatellin (Table 3). At this pH the differences between the wild
type and the mutant fade out.
With this kinetic screening over pH certain features become
apparent. When the mutant is compared with the wild type at given
pH, the changes in the post-flash equilibrium distribution of electrons
are most prominent when antimycin is present (the antimycin phase
is generally smaller in the mutant) but are not seen with the non-Table 2
Rates of flash-induced heme bH reduction in the presence of antimycin (s-1).
pH WT A181T
6 566 386
7 1051 656
9 1791 1301inhibited system (cytochrome c is fully re-reduced in both the wild
type and the mutant). A similar type of change in the distribution of
electrons is also generated by changing pH (the antimycin phase
decreases with lowering pH in both the mutant and the wild type).
3.3. Barrier for electron transfer between the FeS cluster and heme c1
Fig. 5A illustrates a shift in the Em of heme c1 in A181T across pH
and the effect of pH on the Em of the FeS cluster. Since the Em of heme
c1 in A181T is 100 mV lower than that of wild type (Fig. 3, Table 1), it is
reasonable to expect that changes in electron distribution, reminiscent
of a barrier for electron transfer, are correlated with a difference in Ems
between the FeS cluster and heme c1; the lower the Em of heme c1 will
be with respect to the Em of the FeS cluster, the larger the barrier for
electron transfer will be and consequently less of cytochrome cwill get
reduced in the flash experiment. This effect should strongly depend on
pH, as the barrier of potential difference strongly depends on pH (in
the tested pH range the Em of FeS cluster falls with pH increase while
that of heme c1 does not; Fig. 5A and ref. [43]). The about 100mVbarrier
present at pH 7 (the Em7 of the FeS cluster is 320 mV) is much
diminished at pH 9, where the Em of the FeS cluster drops about 120mV
and approaches that of mutated cytochrome c1 (Em9=223 mV;
Table 1). On the other hand, at pH 6 the Em of the FeS cluster raises to
about 350 mV, which increases the barrier present at pH 7. Indeed, the
pHdependenceof the amplitudeof theantimycinphase appears to track
the size of the barrier (the amplitude decreases with decreasing pH as
the barrier increases) (Fig. 5B, circles).
With these considerations, a similar tracking becomes evident also
for the wild type (Fig. 5B, squares). In this case the barrier of potentialFraction of cytochrome c re-reduced in chromatophores containing wild-type
cytochrome bc1 or the A181T mutant after its oxidation by single flash in the presence
of antimycin or myxothiazol (antimycin or myxothiazol phase).
WT A181T
pH 6 pH 7 pH 9 pH 6 pH 7 pH 9
Antimycin phase 0.62 0.77 1 0.46 0.58 0.78
Myxothiazol phase 0.31 0.35 0.50 0.23 0.27 0.50
Fig. 5. Difference in midpoint potential between the FeS cluster and heme c1 and its influence on the post-flash distribution of electrons in the c-chain in the presence of antimycin.
(A) pH-dependence of Em of the FeS cluster (dotted line) and heme c1 in wild type (solid line) and in A181T mutant (dashed line). Horizontal dashed line for A181T is assumed from
the similar values of Emmeasured at pH 7 and 9 (Table 1). (B) The experimentally determined fraction of cytochrome c re-reduced in the wild type (open squares) and A181Tmutant
(open circles) in the presence of antimycin (antimycin phase) is plotted vs. difference in Ems between the FeS cluster and heme c1. Solid line represents the changes in the fraction of
cytochrome c re-reduced simulated for the conditions when antimycin is present by the model described in Fig. 6D.
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absolute value at given pH is smaller comparing to the mutant (Em of
heme c1 is higher) (Fig. 5A). Consequently, the amplitude of the
antimycin phase also decreases with decreasing pH, although its size
at given pH (in particular at pH 6 and 7) is larger than the respective
amplitude in the mutant (Fig. 4, Table 3).
The changes in the barrier of potential difference between the FeS
cluster and heme c1 are also reflected in the changes in the amplitude
of myxothiazol phase. This phase diminishes from about a half of the
total amplitude of the oxidized cytochrome c at pH 9 (in both the wild
type and the mutant), to about one third in wild type or one fourth in
the mutant at pH 7 and 6 (Table 3). Not only this dependency can
again be correlated with increase in the barrier of potential difference,
but also the smaller myxothiazol phase in the mutant at pH 7 or 6 in
comparison to the wild type appears to reflect a larger barrier of
potential difference at these two pHs in the mutant.
It thus become clear that the barrier of the difference in midpoint
potential between the FeS cluster and heme c1 does influence the
post-flash distribution of electrons in the c-chain in the presence of
antimycin or myxothiazol. Dropping a midpoint potential of heme c1
by mutation acts only to enhance the effects and trends naturally
present in the native system. This, in principle, helps in interpreting
the results. However, the electron exchange between the FeS cluster
and heme c1 is only one step in the more complex reaction sequence
involving two chains of cofactors. Thus understanding of the meaning
of the changes in the post-flash distribution of electrons in one chain
under the blockage of the outflow of electrons from the second chain
(the antimycin case) requires modeling.
3.4. Kinetic model of electron flow in the c-chain
We consider the kinetic model which uses the postulates of the
original equilibrium model described in ref. [6]: an adequacy of the
equilibrium redox potential values, the amount of oxidized equiva-
lents per single flash, and a strict coupling of reactions at the Qo site.
The latter postulate accommodates the Q/QH2 exchange at the Qo site
which means that the forward reaction takes place when the QH2,
oxidized FeS and oxidized heme bL are all present at the site, while the
reverse reaction takes place when the Q, reduced FeS and reduced
heme bL are all present at the site. In this model all steps of electron
transfer are reversible and independent of each other. In addition, the
effect of change in distance between cofactors on the electron transfer
coming from the movement of the FeS head domain is simplified to
include just the two states that switch between themselves
independently of any other event in the enzyme. Because all the
experiments were done at Eh equal to the Em of the quinone pool, the
concentrations of Q and QH2 are considered equal.Figs. 5B and 6 show that with these simple assumptions the model
generally reproduces the observed trends and changes in the post-
flash electron distribution in the wild type and the mutant, with and
without inhibitors, at different pHs. This guides us into the following
description of electron transfer reactions.
The full cytochrome c re-reduction in the absence of any inhibitor
consumes electrons from the pre-reduced FeS cluster and then from
quinols that are oxidized at the Qo site in a coupled reaction that
delivers the second quinol-born electron to the b-chain. A complete-
ness of this reaction is a consequence of the unperturbed outflow of
electrons from hemes b to the Qi site and further down to the Q pool.
In another words, a completion of two reactions of QH2 oxidation at
the Qo site secured by an immediate removal of electrons from hemes
b leaves all cofactors in the c-chain (including the FeS cluster) fully
saturated with electrons. The reaction is driven to completion even
when heme c1 has potential 100 mV lower than Em of FeS in the
mutant (Fig. 6, no inhibitor panel). This is consistent with the
observations that the Em of heme c1 can be lowered within this range
without affecting the overall electron flow through the c-chain
[27,44]. In fact, the difference in Ems between heme c1 and the FeS
cluster can be as much as 180 mV and the enzyme still muster enough
electron transfer through cytochrome bc1 to support its functionality
[27].
However, when the outflow of electrons from the b-chain is
blocked with antimycin, the b-chain gets saturated with electrons and
hemes b remain reduced for significant amount of time. This increases
the effective concentration of one of the substrate needed for reverse
reaction at the Qo site (reduced heme bL). The presence of reduced
heme bL can shift the equilibrium of the Qo site reaction depending on
the availability of the other substrates for the reverse reaction
(quinone and the reduced FeS cluster). It follows that, at a given Q
concentration, a probability of the reverse reaction increases as the
effective concentration of reduced FeS cluster at the site increases.
This happens, for example, when the barrier for electron transfer from
the FeS cluster to heme c1 increases, which in our experiments was
achieved either by lowering the Em of heme c1 by mutation or by
increasing the Em of the FeS cluster through the pH change. Once the
oxidation of the second quinol cannot be completed, the c-chain
cannot be fully saturated with electrons and consequently the
equilibrium distribution of electrons in the entire c-chain is shifted
(Fig. 6, antimycin panel). This means a partial backflow of electrons
from cytochrome c reflected as a change between the level of reduced
cytochrome c in the absence and the presence of antimycin. The
model would thus predict that increasing the barrier for electron
transfer from the FeS cluster to heme c1 would result in a decrease of
the amplitude of the antimycin phase (Figs. 5B, 6C), which is
consistent with the experiment (Figs. 4, 5B, Table 3). With this
Fig. 6. Analysis of post-flash electron distribution in wild type and A181T cytochrome bc1. Schemes in A, B comparewild type (WT)with A181T for a given set of conditions. Black and
white squares represent reduced and oxidized cofactors, respectively. Incomplete reduction is represented in a grey scale. Dotted squares mark the cofactors of c-chain that are
observable in the flash experiments. (A) Single flash generates two oxidizing equivalents per cytochrome bc1 (white squares c) [38] at the time where hemes b are oxidized (white
squares bL and bH) and the FeS cluster and heme c1 are reduced (black squares FeS and c1, respectively). (B)Within tens of milliseconds electrons redistribute to reach equilibrium in
which the reduction levels of cofactors vary depending on experimental conditions. In the absence of inhibitors, unperturbed electron flow out of the b-chain upon oxidation of two
QH2 secures complete re-reduction of all cofactors in the c-chain in bothWT and A181T (black squares in no inhibitor panel). In the presence of antimycin, the level of reduced hemes
b available for reverse reaction is higher and the equilibrium is reached before the c-chain is fully reduced. In WT, incomplete oxidation of second QH2 (grey squares in antimycin
panel) leaves FeS partially oxidized, which leads to redistribution of electrons in the entire c-chain, as observed by flash at the level of cytochromes c (note that intensity of squares in
c-chain should be reduced, which for simplicity is not shown). In A181T, incomplete oxidation of second QH2 faces additional barrier of potential difference between FeS and heme c1
which shifts equilibrium toward reduced FeS at the expense of reduced heme c1 (represented as black square FeS and light grey square c1). This increases probability of reverse
reaction and decreases probability of forward reaction at the Qo site, and the level of reduced heme bL may decrease (note that in this case the reduction level of heme c1 determines
the reduction level of heme bL, as represented by light grey squares c1 and bL). In the presence of myxothiazol (myxothiazol panel), electron from pre-reduced FeS cluster
redistributes among the cofactors of the c-chain, but in WT the oxidation of FeS cluster by cytochromes c is more prominent than in A181T (note that for simplicity, for WT a
complete electron transfer from FeS cluster to heme c is shown, white square FeS and black squares c). In the presence of stigmatellin (stigmatellin panel) only cytochromes c are in
equilibrium thus full extent of flash-oxidized cytochromes c is preserved. Panel (C) shows simulations of the traces for the reduction of the observable experimentally cytochromes c
in WT (dashed line) and A181T (solid line) obtained from the model schematically presented in panel (D). The time constants for partial reactions denote k0f/k0b — association/
dissociation rate of Q to/from the Qo site, k1f/k1b — same as k0f/k0b but for QH2, k2f/k2b — two-electron oxidation/reduction of QH2/Q in the Qo site, k3f/k3b — rate constants for
movement of the FeS head domain to/from cytochrome c1 position, k4f/k4b — rate constants for electron transfer from FeS to heme c1 or reverse reaction, k5f/k5b — rate constant for
electron transfer from heme c1 to heme c or reverse reaction. Dotted line in the antimycin panel in C shows the trace simulated for A181T assuming that QH2 oxidation at the Qo site
was concerted but irreversible (i.e., k2b=0 M-1s-1). This illustrates the prediction of how the system would respond if at least one reaction was irreversible (a case not supported
experimentally).
302 E. Cieluch et al. / Biochimica et Biophysica Acta 1797 (2010) 296–303reasoning we can understand why affecting the equilibrium distribu-
tion of electrons in the b-chain in the presence of antimycin affects the
distribution of electrons in the c-chain (see details in Fig. 6).
We note that if the reaction at the Qo site was considered
irreversible, the model would not predict shifts in the presence of
antimycin and cytochrome c reduction would always run to
completion (see Fig. 6C, dotted line). Similarly, a complete cyto-
chrome c reduction would occur if the reduction of the FeS cluster at
the Qo site would be kinetically separated from its oxidation by
cytochrome c (an inherent feature of many gating mechanisms). This
clearly is not supported experimentally.
In the presence of myxothiazol, the situation is simplified to only
include the post-flash equilibrium distribution of electron that
comes from the pre-reduced FeS center. In this case the reductionlevel of cytochrome c again depends of the height of the barrier for
electron transfer from the FeS cluster to heme c1. The model
predicts that increasing the barrier decreases the myxothiazol phase
(Fig. 6, myxothiazol panel) consistent with the experimental
observations (Fig. 4, Table 3).
In conclusion, the variations in the distribution of electrons
demonstrated in flash experiments guide us into an appreciation of
a mechanism in which a shift in the equilibrium of one reaction
influences the equilibrium of all remaining reactions in the cofactor
chains. To allow this, all the reactions must be kinetically coupled and
reversible on a millisecond timescale [6]. This means that, the FeS
cluster, which undergoes a movement during catalysis, must
equilibrate with both of its partners on a millisecond timescale
independently of its redox state and of the redox state of the partners.
303E. Cieluch et al. / Biochimica et Biophysica Acta 1797 (2010) 296–303This would be consistent with a recent observation about a presence
of broad distribution of positions of FeS head domain in native
cytochrome bc1 [45]. Mechanistically, this model does not require any
physical gating, but at the same time it does not preclude it. This
model follows a rather simple description in which the direction of
electron flow through both of the chains exclusively depends on the
rates of all reversible partial reactions, including the Q/QH2 exchange
rate to/from the catalytic sites.
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